910
Participants
Start Date
January 31, 2011
Primary Completion Date
December 31, 2011
Study Completion Date
December 31, 2011
LCZ696
LCZ696 was supplied as tablets in blister cards in 100 mg strengths.
Valsartan
Valsartan was supplied as tablets in blister cards in 160 mg and 320 mg strengths.
AHU377
AHU377 was supplied in tablets in blister cards in 50 mg and 100 mg strengths.
Placebo
Placebo was supplied as tablets in blister cards.
Novartis Investigative Site, Budapest
Novartis Investigative Site, Budapest
Novartis Investigative Site, Törökbálint
Novartis Investigative Site, Miskolc
Novartis Investigative Site, Miskolc
Novartis Investigative Site, Nyiregyháza
Novartis Investigative Site, Csongrád
Novartis Investigative Site, Buffalo
Novartis Investigative Site, Santiago de Compostela
Novartis Investigative Site, Erie
Novartis Investigative Site, Granada
Novartis Investigative Site, Greensboro
Novartis Investigative Site, Greensboro
Novartis Investigative Site, Madrid
Novartis Investigative Site, Shelby
Novartis Investigative Site, Charlotte
Novartis Investigative Site, Clearwater
Novartis Investigative Site, Belzoni
Novartis Investigative Site, Jackson
Novartis Investigative Site, Jackson
Novartis Investigative Site, Seville
Novartis Investigative Site, Tarragona
Novartis Investigative Site, Alzira
Novartis Investigative Site, Chicago
Novartis Investigative Site, Chicago
Novartis Investigative Site, St Louis
Novartis Investigative Site, St Louis
Novartis Investigative Site, Metairie
Novartis Investigative Site, Houston
Novartis Investigative Site, Bryan
Novartis Investigative Site, Henderson
Novartis Investigative Site, Las Vegas
Novartis Investigative Site, Nitra
Novartis Investigative Site, Ludhiana
Novartis Investigative Site, Craiova
Novartis Investigative Site, Lucknow
Novartis Investigative Site, Lucknow
Novartis Investigative Site, Jaipur
Novartis Investigative Site, Oradea
Novartis Investigative Site, Pune
Novartis Investigative Site, Nashik
Novartis Investigative Site, Visakhapatnam
Novartis Investigative Site, Buenos Aires
Novartis Investigative Site, Caba
Novartis Investigative Site, Lanús
Novartis Investigative Site, Caba
Novartis Investigative Site, Corrientes
Novartis Investigative Site, Córdoba
Novartis Investigative Site, Rosario
Novartis Investigative Site, Rosario
Novartis Investigative Site, San Miguel de Tucumán
Novartis Investigative Site, Mount Pearl
Novartis Investigative Site, Mirabel
Novartis Investigative Site, Ste-Foy
Novartis Investigative Site, Érd
Novartis Investigative Site, Szeged
Novartis Investigative Site, Ahmedabad
Novartis Investigative Site, Nashik
Novartis Investigative Site, Bucharest
Novartis Investigative Site, Bucharest
Novartis Investigative Site, Bucharest
Novartis Investigative Site, Barcelona
Novartis Investigative Site, Bucharest
Novartis Investigative Site, Bucharest
Novartis Investigative Site, Nitra
Novartis Investigative Site, Nitra
Novartis Investigative Site, Prešov
Novartis Investigative Site, Bratislava
Novartis Investigative Site, Liptovský Mikuláš
Novartis Investigative Site, Nové Zámky
Novartis Investigative Site, Partizánske
Novartis Investigative Site, Prešov
Novartis Investigative Site, Prešov
Novartis Investigative Site, Ružomberok
Novartis Investigative Site, Sereď
Novartis Investigative Site, Šaľa
Novartis Investigative Site, Zvolen
Novartis Investigative Site, Bucheon-si
Novartis Investigative Site, Goyang-si
Novartis Investigative Site, Uijeongbu-si
Novartis Investigative Site, Seoul
Novartis Investigative Site, Seoul
Novartis Investigative Site, Seoul
Novartis Investigative Site, Koyang
Novartis Investigative Site, Seoul
Novartis Investigative Site, Seoul
Novartis Investigative Site, Seoul
Novartis Investigative Site, Badalona
Novartis Investigative Site, Centelles
Novartis Investigative Site, Alicante
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY